Wendy A. Loughlin

Wendy A. Loughlin

Auto-generated profile, based on publicly available information

Wendy A. Loughlin

School of Environment and Science, Griffith University, Nathan Campus, Nathan, Queensland 4111, Australia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2004 in Chemical Reviews
Verified
Journal Article
Closed access
WLWendy A. Loughlin
Wendy A. Loughlin
Joel TyndallJoel Tyndall
Joel Tyndall
MGMatthew P. Glenn
Matthew P. Glenn
DFDavid P. Fairlie
David P. Fairlie

1 January 2009 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MPMaria J. Petersson
Maria J. Petersson
IJIan Jenkins
Ian Jenkins
WLWendy A. Loughlin
Wendy A. Loughlin
β-Hydroxy amides6 and 7 were treated with triphenylphosphonium anhydride trifluoromethane sulfonate (3), or the cyclic analogue 4, to generate 2-oxazolines 5 and 8 under mild conditions. The reaction was optimised by examining the number of equivalents of reagents 3 or 4, or diisopropylethyl amine required to best effect cyclisation. The effects of altering the reaction temperature, reaction time, concentration, solvent, and addition rate also were investigated. However, it was found that use of a trityl group to block reaction at the hydroxyl or thiol group of the starting amides, and subsequent in situ detritylation, in the absence of base, led to greatly improved yields. Reagent 4 offered significant advantages in the purification of products and was used to dehydrate a range of trityl derivatives to form simple oxazolines, thiazolines, and a dihydro-1,3-oxazine, in high yield (85–99%), as well as a tetrahydro-1,3-oxazepine (31%).

29 March 2019 in Journal of Chemical Education
Verified
Journal Article
Closed access
SCSarah Cresswell
Sarah Cresswell
WLWendy A. Loughlin
Wendy A. Loughlin
MCMark J. Coster
Mark J. Coster
DGDavid M. Green
David M. Green


1 October 2010 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
WLW. A. Loughlin
W. A. Loughlin
Glycogen Phosphorylase (GP) is an important target for the development of anti-hyperglycaemic drugs. GP is an enzyme which is moderated allosterically with multiple ligand binding sites where inhibitors can potentially modulate enzyme activity. The search for potent and isoform selective inhibitors of GP is ongoing with an increasing focus on allosteric inhibition. In this review, the structural diversity, and enzyme interactions of the most recent inhibitors, and in particular allosteric inhibitors, of GP at the different key binding sites are explored. A range of inhibitors of GP, with known as well as unknown binding site or mechanism is presented.

1 September 2015 in Journal of Chemical Education
Verified
Journal Article
Closed access
SCSarah Cresswell
Sarah Cresswell
WLWendy A. Loughlin
Wendy A. Loughlin